Commercial License Terms May Govern Even Without Contracting Officer Knowledge
Client Alert | 1 min read | 07.30.18
On June 27, 2018, in Appeal of CiyaSoft Corporation, the Armed Services Board of Contract Appeals held that the government breached the terms of a commercial software license agreement even though the contracting officer (CO) had not even seen that license. Here CiyaSoft appealed a claim asserting that the Army had breached the terms of its license by using more copies of the software than were permitted. The Army had denied the claim, in part, because the writing between the parties contained no terms specifying how the government would secure and protect the software. However, CiyaSoft had included license terms limiting the software’s use (i) inside the box containing the CDs with the software, (ii) on a piece of paper inside the software’s shrinkwrap, and (iii) in clickwrap that was displayed during the software’s installation process. On appeal, the Board found that although the writing between the parties did not include all of the relevant license terms and the CO never saw or discussed those license terms with CiyaSoft, the CO had a duty to inquire about those license terms and the failure to do so imputed knowledge of the licensing terms on the Army. Highlighting the longstanding policy that the government should accept commercial computer license terms that are customarily provided to other purchasers, the Board held that “the government can be bound by the terms of a commercial software license it has neither negotiated nor seen prior to the receipt of the software, so long as the terms are consistent with those customarily provided by the vendor to other purchasers and do not otherwise violate federal law.”
After finding that the Army could be subject to CiyaSoft’s commercial license terms, the Board then determined that the software was “commercial computer software” under FAR 2.101 because (1) it was developed without government funds, (2) it had been sold to at least one non-governmental entity, and (3) the modifications to the software prior to delivery to the Army did not affect the software’s core purpose.
Insights
Client Alert | 2 min read | 05.09.25
FDA Seeks Stakeholder Consultation on Prescription Drug User Fee Reauthorization
On May 8, the U.S. Food and Drug Administration (FDA) took steps to begin the process for reauthorizing the Prescription Drug User Fee Amendments (PDUFA) by announcing a public meeting to be held on July 14, 2025. The agency invited public stakeholders, including patient and consumer advocate groups, health care professionals, and scientific and academic experts to participate in the meeting and subsequent public meetings to consult on the PDUFA reauthorization.
Client Alert | 2 min read | 05.09.25
New SF-328 for Foreign Ownership, Control, and Influence Assessments Approved, Publication Imminent
Client Alert | 4 min read | 05.08.25
Client Alert | 4 min read | 05.07.25